Investigational study on immunomodulatory effect of lenvatinib in clinical specimens - Future oriented approach for lenvatinib on tumor microenvironment and cancer regression (FLORENCE)
Not Applicable
- Conditions
- Hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000044924
- Lead Sponsor
- Hiroshima University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Lenvatinib was administered after second-line therapy Informed consent for analysis was withdrawn
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the immuno-stimulatory effect of lenvatinib and the change of immune system through lenvatinib treatment using tumor samples by identifying immune cell profiling in tumor tissue before and after lenvatinib treatment
- Secondary Outcome Measures
Name Time Method Progression-free survival, Overall survival